Kristen Landon - 26 Sep 2024 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)

Role: Chief Operating Officer
Signature: /s/ Kristen Landon
Issuer symbol: SXTP
Transactions as of: 26 Sep 2024
Net transactions value: $0
Form type: 4
Filing time: 14 Aug 2025, 21:24:37 UTC
Previous filing: 14 Aug 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Landon Kristen	Chief Operating Officer	C/O 60 DEGREES PHARMACEUTICALS, INC., 1025 CONNECTICUT AVENUE NW SUITE 1000, WASHINGTON	/s/ Kristen Landon	14 Aug 2025	0002053910

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SXTP	Stock Options (Right to Buy)	Award	$0	+4,167		$0.000000	4,167	26 Sep 2024	Common Stock	4,167	$6.85	Direct	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted pursuant to the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan. The options shall vest and become exercisable in five equal tranches on the last date of each fiscal year, with the first vesting date being December 31, 2024. The options have a maximum term of 10 years from the date of grant.
F2	This Form 4 is being filed late due to an inadvertent administrative error.
F3	All information has been retroactively adjusted to reflect the 1-for-5 reverse stock split effected by the Issuer on February 24, 2025.